chr11-747445-TCGCCGCCGCCGC-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The ENST00000528097.5(TALDO1):c.-30_-19del variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00866 in 1,511,000 control chromosomes in the GnomAD database, including 75 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0067 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0089 ( 71 hom. )
Consequence
TALDO1
ENST00000528097.5 5_prime_UTR
ENST00000528097.5 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.357
Genes affected
TALDO1 (HGNC:11559): (transaldolase 1) Transaldolase 1 is a key enzyme of the nonoxidative pentose phosphate pathway providing ribose-5-phosphate for nucleic acid synthesis and NADPH for lipid biosynthesis. This pathway can also maintain glutathione at a reduced state and thus protect sulfhydryl groups and cellular integrity from oxygen radicals. The functional gene of transaldolase 1 is located on chromosome 11 and a pseudogene is identified on chromosome 1 but there are conflicting map locations. The second and third exon of this gene were developed by insertion of a retrotransposable element. This gene is thought to be involved in multiple sclerosis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 11-747445-TCGCCGCCGCCGC-T is Benign according to our data. Variant chr11-747445-TCGCCGCCGCCGC-T is described in ClinVar as [Likely_benign]. Clinvar id is 306085.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00675 (1025/151950) while in subpopulation NFE AF= 0.0101 (683/67894). AF 95% confidence interval is 0.00943. There are 4 homozygotes in gnomad4. There are 475 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TALDO1 | NM_006755.2 | upstream_gene_variant | ENST00000319006.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TALDO1 | ENST00000319006.8 | upstream_gene_variant | 1 | NM_006755.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00676 AC: 1026AN: 151844Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
1026
AN:
151844
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00753 AC: 931AN: 123674Hom.: 2 AF XY: 0.00737 AC XY: 509AN XY: 69020
GnomAD3 exomes
AF:
AC:
931
AN:
123674
Hom.:
AF XY:
AC XY:
509
AN XY:
69020
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00888 AC: 12062AN: 1359050Hom.: 71 AF XY: 0.00862 AC XY: 5801AN XY: 673052
GnomAD4 exome
AF:
AC:
12062
AN:
1359050
Hom.:
AF XY:
AC XY:
5801
AN XY:
673052
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00675 AC: 1025AN: 151950Hom.: 4 Cov.: 33 AF XY: 0.00639 AC XY: 475AN XY: 74280
GnomAD4 genome
AF:
AC:
1025
AN:
151950
Hom.:
Cov.:
33
AF XY:
AC XY:
475
AN XY:
74280
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Deficiency of transaldolase Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at